RNASET2, ribonuclease T2, 8635

N. diseases: 46; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0393591
Disease: AICARDI-GOUTIERES SYNDROME
AICARDI-GOUTIERES SYNDROME
0.030 Biomarker disease BEFREE RNASET2-deficient leukoencephalopathy mimicking congenital CMV infection and Aicardi-Goutieres syndrome: a case report with a novel pathogenic variant. 31349848 2019
CUI: C0393591
Disease: AICARDI-GOUTIERES SYNDROME
AICARDI-GOUTIERES SYNDROME
0.030 GeneticVariation disease BEFREE Leukoencephalopathy with temporal lobe cysts may be associated with monogenetic conditions such as Aicardi-Goutières syndrome or RNASET2 mutations and with congenital infections such as cytomegalovirus. 27843092 2017
CUI: C0393591
Disease: AICARDI-GOUTIERES SYNDROME
AICARDI-GOUTIERES SYNDROME
0.030 Biomarker disease BEFREE Our patients illustrate the clinical and radiological overlap that can be seen between RNASET2-related leukodystrophy and AGS in some cases. 27091087 2016
CUI: C0403823
Disease: Asthenozoospermia
Asthenozoospermia
0.010 Biomarker disease BEFREE Thus, RNASET2 may be a novel biomarker of asthenozoospermia. 29581387 2018
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.010 Biomarker group BEFREE Furthermore, many AID risk SNPs from GWAS have been subsequently fine-mapped in recent Ichip projects, and fine-mapped AID SNPs overlapped with the thymic eQTLs within RNASET2 and SIRPG Finally, in all the eQTL regions, except C2orf74, SNPs underlying the thymic eQTLs were predicted to interfere with transcription factors important in T cell development. 27199374 2016
CUI: C0006111
Disease: Brain Diseases
Brain Diseases
0.300 Biomarker group CTD_human Congenital cytomegalovirus infection and RNASET2 deficiency may both interfere with brain development and myelination through angiogenesis or RNA metabolism. 19525954 2009
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE Indeed, hyperexpression of RNASET2 is able to control tumorigenesis by recruiting macrophages (mostly of the anticancer M1 subtype) at the tumor sites. 23630276 2013
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE Moreover, RNASET2-mediated suppression of tumorigenesis and metastasis was not affected by a double point mutation targeted to the putative ribonuclease catalytic sites, suggesting that tumor suppression by RNASET2 is not mediated by its ribonuclease activity. 15809705 2005
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.010 Biomarker group BEFREE RNASET2 is an extracellular ribonuclease endowed with a marked antitumorigenic role in several carcinomas, independent from its catalytic activity. 30813308 2019
CUI: C0206695
Disease: Carcinoma, Neuroendocrine
Carcinoma, Neuroendocrine
0.010 Biomarker disease BEFREE New insights into hypoxia-related mechanisms involved in different microvascular patterns of bronchopulmonary carcinoids and poorly differentiated neuroendocrine carcinomas. Role of ribonuclease T2 (RNASET2) and HIF-1α. 29763721 2018
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.020 Biomarker disease BEFREE Altogether, these data suggest that drugs targeting activated src might represent a therapeutic approach for RNASET2-expressing EOCs. 30813308 2019
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.020 Biomarker disease BEFREE The integrated results suggested that RNASET2 and GGNBP2 contributed to drug resistance in ovarian cancer, via direct or indirect interactions with a number of microRNAs, genes and proteins involved in a wide range of biological processes and pathways. 24842157 2014
Congenital cytomegalovirus infection
0.020 Biomarker disease BEFREE RNASET2-deficient leukoencephalopathy mimicking congenital CMV infection and Aicardi-Goutieres syndrome: a case report with a novel pathogenic variant. 31349848 2019
Congenital cytomegalovirus infection
0.020 Biomarker disease BEFREE Congenital cytomegalovirus infection and RNASET2 deficiency may both interfere with brain development and myelination through angiogenesis or RNA metabolism. 19525954 2009
CUI: C0275544
Disease: Congenital infectious disease
Congenital infectious disease
0.020 GeneticVariation group BEFREE Leukoencephalopathy with temporal lobe cysts may be associated with monogenetic conditions such as Aicardi-Goutières syndrome or RNASET2 mutations and with congenital infections such as cytomegalovirus. 27843092 2017
CUI: C0275544
Disease: Congenital infectious disease
Congenital infectious disease
0.020 Biomarker group BEFREE However, some genetic diseases, in particular Aicardi-Goutières syndrome, Band-like calcification, and RNASET2-related disease, may mimic congenital infection; therefore, a full consideration of the radiological and clinical features is necessary before concluding that congenital infection is the cause. 24372060 2014
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.010 Biomarker disease BEFREE We identified decreased expression of RNASET2 as a component of TL1A-mediated increase in production of IFNG and as a potential biomarker for patients with severe CD. 28400196 2017
CUI: C0010709
Disease: Cyst
Cyst
0.010 GeneticVariation disease BEFREE Cystic leukoencephalopathy without megalencephaly is a disorder related in some cases to RNASET2 mutations and characterized by bilateral anterior temporal subcortical cysts and multifocal lobar white matter lesions with sparing of central white matter structures. 27091087 2016
Diabetes Mellitus, Insulin-Dependent
0.010 GeneticVariation disease BEFREE The analysis of T1D identified one region already known to be associated with T1D (INS: p = 3.13 × 10<sup>-7</sup>) and three novel regions (RNASET2, PLEKHA1, and PPIL2; 5.42 × 10<sup>-6</sup> > p > 2.31 × 10<sup>-6</sup>). 29310926 2018
CUI: C0085584
Disease: Encephalopathies
Encephalopathies
0.300 Biomarker group CTD_human RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. 19525954 2009
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 Biomarker disease BEFREE RNASET2 deficiency in humans is associated with infant cystic leukoencephalopathy, which causes psychomotor impairment, spasticity and epilepsy. 29752287 2018
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.010 Biomarker disease BEFREE Altogether, these data suggest that drugs targeting activated src might represent a therapeutic approach for RNASET2-expressing EOCs. 30813308 2019
CUI: C0015944
Disease: Fetal Membranes, Premature Rupture
Fetal Membranes, Premature Rupture
0.100 GeneticVariation phenotype GWASCAT A genome-wide association study of early spontaneous preterm delivery. 25599974 2015
CUI: C4024946
Disease: Focal white matter lesions
Focal white matter lesions
0.100 Biomarker phenotype HPO
CUI: C0018213
Disease: Graves Disease
Graves Disease
0.320 GeneticVariation disease BEFREE Our results suggest that the rs9355610 tag SNP of RNASET2 gene is positively associated with susceptibility to GD in the Chinese Han population. 25928629 2015